Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. - Wikidata - awgldk - TriplyDB

Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.

Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.

http://www.wikidata.org/entity/Q39750331

about

Low dose naltrexone for induction of remission in Crohn's disease Low dose naltrexone for induction of remission in Crohn's disease The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review Nigella sativa (black cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptors Low-dose naltrexone therapy improves active Crohn's disease Opioids and the skin--where do we stand?Opioids: Modulators of angiogenesis in wound healing and cancer.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens.Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signaling Activation of μ opioid receptors modulates inflammation in acute experimental colitis.Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.Disruption of gut homeostasis by opioids accelerates HIV disease progression Opioids and the gut: pharmacology and current clinical experience.RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.Differential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis.Gallotannin-Enriched Extract Isolated from Galla Rhois May Be a Functional Candidate with Laxative Effects for Treatment of Loperamide-Induced Constipation of SD Rats Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study.Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice.Anti-inflammatory effects of Lacto-Wolfberry in a mouse model of experimental colitis.Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma Glafenine-induced intestinal injury in zebrafish is ameliorated by μ-opioid signaling via enhancement of Atf6-dependent cellular stress responses Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.Morphine induces splenocyte trafficking into the CNS.Effects of methylnaltrexone on guinea pig gastrointestinal motility.Emerging neuropeptide targets in inflammation: NPY and VIP Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3.Battle of animal models.Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse.Peripheral mechanisms of pain and analgesia.Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice CEACAM1 and the regulation of mucosal inflammation.The endogenous cannabinoid system protects against colonic inflammation.Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.Opioids for the treatment of arthritis pain.Successful Treatment with Methylnaltrexone and IVIG for Paraneoplastic Syndrome-Associated Intestinal Pseudo-Obstruction.Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications.

P2860

Q24200319-A15B714B-9B5E-4008-B589-E59259A0EC5B Q24201218-A9155226-C0AA-4A73-847D-6D93349EBB83 Q26851158-9622D7BA-EA6F-4411-B712-74ACF3C78269 Q27300141-0F0CE60A-ED08-4AEC-9CC9-43EA4E844E30 Q28283321-5E9E2CD2-013A-4761-9C03-C49DE7A36DDF Q33347020-F8E834A9-817C-49BD-BDA6-40541AB459E9 Q33649031-C1F3222A-A0BE-4D30-A8FB-8492DF3F64F3 Q34233126-75180190-48B0-44A1-8F3E-2D2081052A28 Q34551407-D2349233-B286-428F-82AF-BCD10CF49C71 Q34569178-EB0C3204-3FB4-41C7-9B5C-B25D364DF280 Q35168195-0B3E5F16-5684-4C5A-9AA3-B7B121D991BD Q35510067-A751AB08-3C31-4A90-8BAD-616CCEAE8CFA Q35760524-4179D82D-DCAA-4C0B-A94B-BA31FE831950 Q35782918-A5C4B5AA-56EC-44DB-BED8-AC5203A93899 Q35860904-E6554780-0D0F-4541-AE6E-AEA01DA8F526 Q35906057-3E4C2409-844D-4A86-BCF7-8DBD4E3A659C Q36014007-A012711A-F8BF-44D6-BCE1-58F1619CB869 Q36087227-CD8AB968-03BA-4D63-A420-A688F92E7310 Q36130003-6A734CF0-4FAF-434D-A78C-9A39DAD47210 Q36185519-3AB510DA-D16D-47FC-A991-9EBF664057EE Q36227327-6146BE4D-DCD3-40A2-895D-4FCB8611B642 Q36316681-A3708379-145E-4DAB-A301-F558F4BC6623 Q36403491-8524F652-B47D-49BA-8417-0E381DF5B73C Q36486032-3C64686B-C4A2-4ADE-BA73-69EF4009BC16 Q36503299-1A7A371D-3290-475F-93DF-BDB792577AEC Q36603264-5AD3D251-587B-4CCF-8BA6-2FD9DC4673F3 Q36854395-30FAF3D1-2742-442E-AA0D-D711739B448D Q36923640-CBB0E635-1BB4-4EDF-B8AF-3A028108D508 Q36955485-F13E5D96-B4AB-4A08-842A-EDA0DFB52255 Q37000714-7A7FBC3C-3D92-4F48-B734-7213C5E43D71 Q37015533-DE896000-B02B-4234-B58F-6E3A27BE7AA1 Q37116354-724DDF3A-80BA-4CF1-AC8D-9A0CE9016D16 Q37314270-B51A24E0-D67F-47FA-8CDF-C2B4A6EB09A9 Q37340687-7AF2A26E-C904-476B-9A97-39267C3CECA4 Q37349774-A1491857-082D-4CE0-8B18-95A4AAC75965 Q37370275-0A3868BD-535F-43A2-923F-6A3CCF42ABFB Q37491434-338F056E-9484-4547-9F43-14A82CE2C9B6 Q38166805-B85593E4-1D2B-43A0-AE1D-82F5F32227B5 Q38618026-25C72436-9FAE-4E4C-8CE1-39B383B96DFC Q38911748-5F93824C-821D-4098-8BE7-72B995309E41

P2860

Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.

http://www.wikidata.org/entity/Q39750331

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Anti-inflammatory properties o ...... eatment of colon inflammation.

@en

Anti-inflammatory properties o ...... eatment of colon inflammation.

@nl

type

label

Anti-inflammatory properties o ...... eatment of colon inflammation.

@en

Anti-inflammatory properties o ...... eatment of colon inflammation.

@nl

prefLabel

Anti-inflammatory properties o ...... eatment of colon inflammation.

@en

Anti-inflammatory properties o ...... eatment of colon inflammation.

@nl

P1433

Q39750331-8FDF6F99-D195-45FF-96FF-A226649025D9

P1476

Q39750331-780BEA45-248F-4594-A92A-F1C2368990C2

P2093

Q39750331-060014C2-628A-48C0-92CB-F4160B34DAEF

Q39750331-13C2849C-69CD-467E-8C5B-7D3FF2D14AE2

Q39750331-17BEE4F2-81D8-4C87-B331-6D95EBBE3A08

Q39750331-961EBBF7-5A41-49C9-AC7F-7DFCD88DD09C

Q39750331-B0A93C90-ADA3-49A4-BEFF-649D6638329E

Q39750331-BA3671E5-4F8D-454E-A059-6EBE6C96CE07

Q39750331-EE0203BA-CD98-44C1-86FD-9A6CC3E13529

P2860

Q39750331-05FC56BA-ECE4-44AC-9D40-9E6337D41F6E

Q39750331-07238BBB-E59F-4388-9395-4B1AAA9683D9

Q39750331-0972ABC2-6877-4C72-A797-5DE09897FD8B

Q39750331-1520B4FD-4CC8-47DA-B2C9-70EFD01EC351

Q39750331-15E4DFA4-5109-4428-AF81-811B0D0421BF

Q39750331-1A10FC8E-333E-4C1F-ABB8-4BED225B9B95

Q39750331-20A2E75E-99BA-48E8-8056-58A45DF8AD66

Q39750331-25DE5643-CB4A-42E2-9BD0-B22FB92AB5BC

Q39750331-329BC123-FF1D-41AD-BD5B-7D227886A974

Q39750331-362ED0BC-0F2A-4F67-9E06-B524AAC6678B

P304

Q39750331-8AA370C6-B787-4673-8503-8F34B9DDE518

P31

Q39750331-9328776B-9C1A-4181-83B1-5B10D99538AC

P356

Q39750331-F2F7518D-B97B-4F3D-9B6F-5B68D8C4B7C7

P407

Q39750331-E83CCBF2-B5EB-46C7-9FF5-8E2ED982E044

P433

Q39750331-7792C172-A3AF-4192-AA20-F4D13A9370B6

P478

Q39750331-9329B371-3DC1-4806-A5CF-189CC9B4E199

P50

Q39750331-0C37C1BB-9417-4C37-B968-1EDB8ECE8BC6

Q39750331-D8D4615A-E7CE-4720-9282-3BB3E7607C3D

P577

Q39750331-61A493FD-41C1-469D-BA93-40F2C1D771A9

P698

Q39750331-9B46AFCD-1E86-4E44-8125-081FF927DD8A

P921

Q39750331-2954CA5F-A043-4AB7-A74B-EF96CD3A2793

Q39750331-645792E2-8706-4E67-B875-293D3D3FAC7F

P932

Q39750331-1980884B-A319-4256-BBD0-80CDBF1CD815

P356

P1433

Journal of Clinical Investigation

P1476

Anti-inflammatory properties o ...... eatment of colon inflammation.

@en

P2093

Brigitte L Kieffer

http://www.w3.org/2001/XMLSchema#string

Claire Gaveriaux-Ruff

http://www.w3.org/2001/XMLSchema#string

David Philippe

http://www.w3.org/2001/XMLSchema#string

Hervé Groux

http://www.w3.org/2001/XMLSchema#string

Laurent Dubuquoy

http://www.w3.org/2001/XMLSchema#string

Myriam Tran Van Chuoï-Mariot

http://www.w3.org/2001/XMLSchema#string

Valérie Brun

http://www.w3.org/2001/XMLSchema#string

P2860

The organization, promoter analysis, and expression of the human PPARgamma gene

Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses

Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.

Opiate binding sites in the cellular immune system: expression and regulation.

Expression of functional mu-opioid receptors during T cell development.

Modulation of respiratory frequency by peptidergic input to rhythmogenic neurons in the preBötzinger complex.

Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers.

Role of cytokines in the pathogenesis of inflammatory bowel disease.

P304

1329-1338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200316750

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Frédéric Colombel

Pierre Desreumaux

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12727924

http://www.w3.org/2001/XMLSchema#string

P921

P932

154442

http://www.w3.org/2001/XMLSchema#string